Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARILYN BERZIN

Allopathic & Osteopathic Physicians Dermatology

NPI
1043286362
CMS profile
91982
Location
WASHINGTON, DC

General Payments · PY2018–2024

$2,343.61

  • Reported across 94 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$578.04

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $578.04 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
REVANCE THERAPEUTICS, INC. $318.13 8
ABBVIE INC. $188.29 4
Incyte Corporation $25.25 1
Regeneron Healthcare Solutions, Inc. $24.23 1
Galderma Laboratories, L.P. $22.14 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $358.05 20
PY2019 $429.74 22
PY2020 $131.17 6
PY2021 $318.72 14
PY2022 $227.31 8
PY2023 $300.58 9
PY2024 $578.04 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $109.46 04/26/2024 Food and Beverage Undisputed 01/23/2026 1103316996 CMS
ABBVIE INC. $22.69 08/08/2024 Food and Beverage Undisputed 01/23/2026 1103316998 CMS
ABBVIE INC. $28.20 09/25/2024 Food and Beverage Undisputed 01/23/2026 1103317000 CMS
ABBVIE INC. $27.94 11/22/2024 Food and Beverage Undisputed 01/23/2026 1103317002 CMS
Galderma Laboratories, L.P. $22.14 10/16/2024 Food and Beverage Undisputed 01/23/2026 1145286321 CMS
Incyte Corporation $25.25 08/02/2024 Food and Beverage Undisputed 01/23/2026 1141236215 CMS
Regeneron Healthcare Solutions, Inc. $24.23 09/16/2024 Food and Beverage Undisputed 01/23/2026 1114009543 CMS
REVANCE THERAPEUTICS, INC. $17.44 01/17/2024 Food and Beverage Undisputed 01/23/2026 1147912736 CMS
REVANCE THERAPEUTICS, INC. $79.79 05/17/2024 Food and Beverage Undisputed 01/23/2026 1147912738 CMS
REVANCE THERAPEUTICS, INC. $17.59 05/23/2024 Food and Beverage Undisputed 01/23/2026 1147912740 CMS
REVANCE THERAPEUTICS, INC. $11.65 06/11/2024 Food and Beverage Undisputed 01/23/2026 1147912742 CMS
REVANCE THERAPEUTICS, INC. $22.96 07/19/2024 Food and Beverage Undisputed 01/23/2026 1147912744 CMS
REVANCE THERAPEUTICS, INC. $10.54 08/28/2024 Food and Beverage Undisputed 01/23/2026 1147912746 CMS
REVANCE THERAPEUTICS, INC. $50.00 11/16/2024 Food and Beverage Undisputed 01/23/2026 1147912748 CMS
REVANCE THERAPEUTICS, INC. $108.16 12/12/2024 Food and Beverage Undisputed 01/23/2026 1147912750 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.